Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2036 participants.

Also called NCT03620760

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,036 participants (planned count) (from the registry)
Sponsor
Xiaofan Wu (from the registry)
Registry
  • NCT NCT03620760
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03620760. Randomized; no masking; primary purpose treatment. Start 2018-08-07 (actual); primary completion 2020-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
Condition
Unstable Angina Pectoris
Condition
Coronary Stent Implantation
Intervention (Drug)
Ticagrelor 90 mg
Intervention (Drug)
Ticagrelor 45 mg
Intervention (Drug)
Aspirin
Lead sponsor
Xiaofan Wu (class: other)

Record details

Record id
cardio:ct-nct03620760
Content hash
f44b7fe29b014ee37c695b5e3afa9b65d58018859ee1dc669d1fc9948f0b0b7b